286 related articles for article (PubMed ID: 2079449)
1. In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.
Cooper MA; Andrews JM; Ashby JP; Matthews RS; Wise R
J Antimicrob Chemother; 1990 Nov; 26(5):667-76. PubMed ID: 2079449
[TBL] [Abstract][Full Text] [Related]
2. The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.
Wise R; Andrews JM; Brenwald N
J Antimicrob Chemother; 1993 Jan; 31(1):73-80. PubMed ID: 8383104
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of four new fluoroquinolones.
García-Rodríguez JA; García Sánchez JE; García García MI; Fresnadillo MJ; Trujillano I; García Sánchez E
J Antimicrob Chemother; 1994 Jul; 34(1):53-64. PubMed ID: 7961215
[TBL] [Abstract][Full Text] [Related]
4. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Bauernfeind A
J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
[TBL] [Abstract][Full Text] [Related]
5. The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents.
Child J; Andrews J; Boswell F; Brenwald N; Wise R
J Antimicrob Chemother; 1995 Jun; 35(6):869-76. PubMed ID: 7559198
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
[TBL] [Abstract][Full Text] [Related]
7. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
Wise R; Brenwald NP; Andrews JM; Boswell F
J Antimicrob Chemother; 1997 Apr; 39(4):447-52. PubMed ID: 9145816
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of tosufloxacin, a new quinolone antibacterial agent.
Cooper MA; Andrews JM; Wise R
J Antimicrob Chemother; 1992 Jun; 29(6):639-47. PubMed ID: 1506348
[TBL] [Abstract][Full Text] [Related]
9. The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.
Wise R; Andrews JM; Brenwald N
J Antimicrob Chemother; 1993 Apr; 31(4):497-504. PubMed ID: 8390433
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
Cooper MA; Andrews JM; Wise R
J Antimicrob Chemother; 1992 May; 29(5):519-27. PubMed ID: 1320603
[TBL] [Abstract][Full Text] [Related]
11. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.
Jones RN; Ballow CH; Schentag JJ; Johnson DM; Deinhart JA
Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of sparfloxacin compared with those of five other quinolones.
Cantón E; Pemán J; Jimenez MT; Ramón MS; Gobernado M
Antimicrob Agents Chemother; 1992 Mar; 36(3):558-65. PubMed ID: 1320362
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro activity of two new quinolones: rufloxacin and MF 961.
Wise R; Andrews JM; Matthews R; Wolstenholme M
J Antimicrob Chemother; 1992 Jun; 29(6):649-60. PubMed ID: 1324239
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.
Ballow CH; Jones RN; Johnson DM; Deinhart JA; Schentag JJ
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):173-86. PubMed ID: 9401810
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
Harnett SJ; Fraise AP; Andrews JM; Jevons G; Brenwald NP; Wise R
J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Hoogkamp-Korstanje JA
J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]